1. Prognostic Role of Thymidylate Synthase Polymorphisms in Gastric Cancer Patients Treated with Surgery and Adjuvant Chemotherapy
   Kazuyuki Kawakami et al, 2005, Clinical Cancer Research CrossRef
2. Biological Markers as a Predictor for Response and Prognosis of Unresectable Gastric Cancer Patients Treated with Irinotecan and Cisplatin
   Fumio Nagashima et al, 2005, Japanese Journal of Clinical Oncology CrossRef
3. A Pharmacogenetic Study of VDR fok1 and TYMS Polymorphisms and Their Association With Glucocorticoid-Induced Osteonecrosis in Egyptian Children With Acute Lymphoblastic Leukemia
   Dina ElHarouni et al, 2018, Frontiers in Oncology CrossRef
4. Bcl-2 Expression as a Predictive Marker of Hormone-Refractory Prostate Cancer Treated with Taxane-Based Chemotherapy
   Tateki Yoshino et al, 2006, Clinical Cancer Research CrossRef
5. Impact of E2F-1 Expression on Clinical Outcome of Gastric Adenocarcinoma Patients with Adjuvant Chemoradiation Therapy
   Jeeyun Lee et al, 2008, Clinical Cancer Research CrossRef